Leadership

Chief Executive Officer

Greg Behar joined Recipharm as CEO on 1 January 2024.
With a profound commitment to a 'customer-first' approach, Greg’s vision for Recipharm is to be the leader in delivering high-quality solutions that drive success for its customers.

Greg joined Recipharm from Nestle Health Science (NHSc) where he was CEO, and a member of the Nestlé Executive Board. Prior to NHSc, Greg held the position of CEO at Boehringer Ingelheim Pharmaceuticals USA and led a zone leadership for the Group. His extensive experience includes pivotal roles at Novartis in general management, sales and marketing in Spain and the European zone. Greg also worked at Novartis in general management, sales and marketing roles.

Currently serving on the boards of Sonova AG and Amazentis SA, Greg has a notable history of board memberships, including Prometheus Bioscience (acquired in 2023 by Merck for $11Bio), Seres Therapeutics, and Axcella Health.

Greg holds an MBA from INSEAD, a Masters in Engineering from the Institute of Technology of Switzerland (EPFL) and a BS in Mechanical Engineering from UCLA.

Chief Financial Officer

Rodolfo J. Savitzky joined Recipharm as Chief Financial Officer on 1 October 2025. He brings extensive international experience in finance and strategy, with a strong track record of driving sustainable growth, enhancing operational excellence, and developing people and teams to deliver long-term value.  

Most recently, Rodolfo was CFO and member of the Executive Board at SoftwareOne, where he led an operational excellence programme that supported profitable business expansion and paved the way for a major acquisition completed in mid-2025, generating significant synergies and earnings accretion. 

Rodolfo is recognised for his deep expertise in the pharmaceutical industry. From 2016 to 2021, he served as CFO and member of the Group Executive Committee at Lonza, where he played a central role in transforming the company into a pure-play pharma services leader.  In 2021, he also served as Non-Executive Director and Chairman of the Audit Committee of Unilabs, until its sale to A.P. Moller Holding. Earlier, Rodolfo spent more than a decade at Novartis in senior finance and strategy roles across multiple business units and corporate teams. As CFO of Novartis Animal Health, he drove growth and margin expansion and oversaw the division’s successful sale to Eli Lilly in 2015. 

Currently a Non-Executive Director and Chairman of Audit Committees at several international companies, Rodolfo contributes his financial expertise and industry insight at board level. 

Rodolfo holds a Bachelor’s degree in Industrial and Systems Engineering from the Monterrey Institute of Technology and Higher Education in Mexico and an MBA in Finance and Economics from the University of Chicago Booth School of Business in the USA.

Chief Operating Officer

Luc joined Recipharm in April 2022 as Chief Operating Officer. His role involves not only overseeing manufacturing operations but also aligning them with the overarching goals of the organisation, ensuring a seamless integration of operational efficiency with customer satisfaction. Luc leads the Group’s business processes and spearheads its digitalisation strategy. Additionally, he supervises regulatory affairs, quality management, and Health and Safety initiatives throughout the organisation, fostering a culture of continuous improvement. His strategic vision and hands-on experience position him as a key driver in Recipharm's operational success and the Group’s ability to deliver high-quality solutions to its customers.

Drawing on his extensive global industrial experience, Luc specialises in cultivating profitable, sustainable and resilient supply chain and operations activities for international corporations. Throughout his extensive career, he has held instrumental positions, notably as the Head of Operations at Sartorius Stedim Biotech, and as the Managing Director at Catalent Pharma Solutions, where he actively shaped the company's strategic trajectory. Luc's professional journey also includes holding various leadership positions at Forvia, where he demonstrated his proficiency in Quality, Research and Development, and Lean Operations. His multifaceted expertise has been instrumental in shaping operational strategies and optimising processes to achieve efficiency and quality in pharmaceutical manufacturing.

Luc holds an Adv. M. Sci. in Inventive Design from the French National Institute of Applied Science, a BSc in Quality Management from the University of Paris Cergy-Pontoise, and a BTech in Electronics from Strasbourg’s High Tech School.

Chief Commercial Officer 

Neil joined Recipharm in August 2025 as Chief Commercial Officer, bringing with him more than 25 years of experience in the CDMO industry and a deep passion for building successful, customer-centric strategies for patients and consumers around the world.

Driven by a belief in the power of collaboration and high-performing teams, Neil thrives on creating environments where people are empowered to deliver results. His leadership has consistently helped businesses grow by aligning commercial teams around clear goals and customer needs.

Neil’s global experience spans commercial, operational and quality leadership across several major pharmaceutical organisations. Most recently, he served as Chief Commercial Officer at Aenova, where he oversaw significant growth in new business and contributed to a successful sale of the company. Prior to that, he held senior leadership roles at Catalent and led the Vaccines Manufacturing and Innovation Centre (VMIC) in the UK as CEO through its acquisition.

Having worked extensively across international markets, Neil brings a strong appreciation for cultural diversity and a proven ability to unite global teams around a shared vision.

Neil holds a BSc in Chemistry from the University of Bristol and a Postgraduate Certificate in Management from the University of the West of England. With a positive energy and pragmatic leadership style, he thrives in collaborative environments where high-performing teams are inspired to win and deliver exceptional results.

President Advanced Bio, Recipharm’s biologics business unit. 

Vikas assumed the role of President at Advanced Bio, the biologics business unit of Recipharm, in May 2023. Since taking charge, he has dedicated his efforts to fostering excellence, with a particular emphasis on advancing xRNA manufacturing, plasmid DNA, viral vector, live virus and microbiome live therapeutics within the division. Committed to cultivating a culture of teamwork and collaboration, Vikas is driven by a passion for ensuring customer satisfaction, fostering workplace respect and achieving both commercial and operational excellence throughout the organisation. 

With over two decades of experience in the life science industry, Vikas has held various senior positions in pharma and bioprocessing companies such as Repligen, GE Healthcare, Merck Millipore and Bayer. His extensive background encompasses roles in general management, commercial operations, product management, corporate finance, business strategy, and mergers and acquisitions.

In his spare time, Vikas reads history, listens to jazz, and enjoys travelling to pursue his passion for wildlife photography. Vikas holds a Bachelor of Engineering (BEng), Chemical from the Malaviya National Institute of Technology, Jaipur; an MBA from the Institute of Management Technology, Ghaziabad; and MS in Finance from Bentley University.

Group General Counsel

Emmanuel joined Recipharm in February 2022 as Group General Counsel, Chief Compliance Officer and Board Secretary. In his role, Emmanuel directs his focus towards governance, M&A & divestitures, corporate compliance, disputes & litigation, contract management. Striking the right balance between challenge and support, he facilitates optimal decision-making and enables businesses to achieve organisational and cultural change and mitigates risks pragmatically. Emmanuel plays a vital role in efficiently supporting business strategy and goals, seizing commercial opportunities, and strategically placing Legal, Compliance, IP, and Data protection functions at the core of the group's corporate strategy.

Emmanuel brings a broad international experience, having studied or worked in Switzerland, Hong Kong, Japan, and Dubai. Prior to joining Recipharm, he served as Group General Counsel and Chief Compliance Officer for PHC Group (former Panasonic Healthcare) and held various Legal & Compliance leadership positions for the Bayer Group, after having worked in private practice for a Swiss leading law firm.

A Swiss-qualified lawyer, Emmanuel holds a Lic. Jur. from the University of Fribourg, Switzerland, an LL.M. from the City University of Hong Kong, and a Certified Information Privacy Professional/Europe (CIPP/E) accreditation.

Head of Human Resources

Jackie was appointed Head of Human Resources for the Recipharm Group, in January 2024. In her pivotal role, Jackie directs her efforts towards overseeing the Human Resources function for the entire Group. She is dedicated to ensuring that HR policies, processes and activities align seamlessly with the overarching Group strategy. Jackie is deeply passionate about promoting respect and inclusion within the workplace, fostering a collaborative culture that enhances the overall employee experience.

Jackie’s journey with Recipharm began in October 2018, marked by the acquisition of the Holmes Chapel, UK, site from Sanofi, where Jackie was a member of the Site Leadership Team and Head of HR.

Before moving into Human Resources, Jackie held various roles, including the Holmes Chapel site Operations management as well as leading functions within Product Development and Quality, showcasing her versatility and leadership skills. This diverse background equips Jackie with a unique perspective, allowing her to integrate operational insights into her HR leadership role. Her ability to lead from the front and deliver results in a changing environment has ensured her continued success and will promote the future success and well-being of the Recipharm Group. 

Jackie holds a BSC (Hons) in Chemistry from Leicester University, UK, a Post Graduate Certificate in Management and the CIPD Level 5 Diploma in Human Resources Management. 

Head of communication

Guenaelle joined Recipharm in October 2022 as Head of Communication for the Group. 

Leveraging her strategic communication expertise, Guenaelle plays a crucial role in elevating Recipharm's communication and fostering a vibrant organisational culture. Driven by the power of effective communication, she advances the corporate brand visibility through media relations, digital communication and employee engagement. Guenaelle enjoys spotlighting successes and the exceptional contributions and accomplishments of individuals to the organisation's overall success. 

A true believer that “No one can whistle a symphony, it takes a whole orchestra to play it”, Guenaelle thrives on teamwork and collaboration, at all levels in the organisation. Her wealth of experience extends to leading communication strategies for M&A, divestment and organisational transformations. She is a seasoned spokesperson, possessing extensive expertise in developing effective communication approaches amid crises and issues to safeguard the brand. 

With a rich background in working for both private and listed organisations, Guenaelle has served as the Head of Communications at LGC and prior experiences encompass diverse communication and marketing responsibilities at Air Products, Inc. and Logica PLC.

Guenaelle holds a BA (Hons) in European Business Administration from Middlesex University (UK) and from the CESEM (Reims, France) and the CIPD Level 5 Diploma in Human Resources Management.